Horizon Therapeutics Plc
HZNP
Market Cap$0
Close$
$273.77
135.4% upside
Current Fair Value
135.4% upsideUndervalued by 135.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $92.84 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.28 |
| Beta | 1.01 |
| Outstanding Shares | 228,743,143 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 51.1 |
|---|---|
| PEG | 47.14 |
| Price to Sales | 7.75 |
| Price to Book Ratio | 5.06 |
| Enterprise Value to Revenue | 0.03 |
| Enterprise Value to EBIT | 0.17 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 27.55 |
| Debt to Equity | 0.48 |
Revenue Sources
No data
Insider Trades
ESG Score
No data